The Truth Behind Why Were Monoclonal Antibodies Banned for Some Uses
•
4 min read
Between 2021 and 2023, the U.S. Food and Drug Administration (FDA) revoked Emergency Use Authorizations for several specific COVID-19 treatments. While this led to public questions asking why were monoclonal antibodies banned, the reality is more nuanced, involving a complex interplay of viral evolution, therapeutic effectiveness, and evolving safety data.